Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN on January 25, 2024

08.01.2024 - BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) - Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today ... Seite 1

Related Keywords

New York ,United States ,Brisbane ,Queensland ,Australia ,Richard Lafayette ,Jonathan Barratt ,Lotte New York Palace Hotel ,Stanford University Medical Center ,University Of Leicester ,Vera Therapeutics Inc ,Nasdaq ,New York Palace Hotel ,Vera Therapeutics Registereda Chart ,Era Therapeutics Registereda Kurs ,Era Therapeutics Registereda Aktie ,